A hyaluronic acid-modified cyclodextrin self-assembly system for the delivery of β-carotene in the treatment of dry eye disease

F Zhang, M Tan, ZE Hu, YT Zhang, XW Qi… - International Journal of …, 2025 - Elsevier
Dry eye disease (DED) is a multifactorial ocular disease, the core mechanism of which is the
tear film instability caused by ocular oxidative stress damage and inflammation. Although …

Anti-oxidative mesoporous polydopamine-based hypotensive nano-eyedrop for improved glaucoma management

Y Huang, X Ding, L Zhu, X Zhang, X Wang, F Ma… - Colloids and Surfaces B …, 2025 - Elsevier
Conventional hypotensive eye drops remain suboptimal for glaucoma management,
primarily due to their limited intraocular bioavailability and the growing concern regarding …

Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents

M Brugnera, M Vicario-de-la-Torre… - Drug Delivery and …, 2024 - Springer
The first line of glaucoma treatment focuses on reducing intraocular pressure (IOP) through
the prescription of topical prostaglandin analogues, such as latanoprost (LAT). Topical …

Levofloxacin-loaded silicone contact lenses materials for ocular drug delivery

X Guo, Y Sun, J Qiao, B Fan… - Journal of Biomaterials …, 2024 - journals.sagepub.com
Silicone contact lenses (SCL), as an emerging ocular drug delivery system, achieve
controlled drug release. However, the existing drug loading methods have limitations such …

[PDF][PDF] Oil-in-water nanoemulsions for glaucoma treatment: An insight into the latest trends

A Kishore, AK Mahor, NK Singh, PP Singh, P Rathore… - BioImpacts, 2024 - bi.tbzmed.ac.ir
Glaucoma is a serious eye disease characterized by elevated intraocular pressure, which
can ultimately lead to blindness, making it the second leading cause of blindness worldwide …